You are using an older browser version. Please use a supported version for the best MSN experience.

Innovent Biologics CEO on Pharma Industry, Prices, Pipeline, Cancer Cure

Mar.21 -- Michael Yu, co-founder, chief executive officer and president of Innovent Biologics, discusses the outlook for the pharma industry, reducing healthcare costs, how a price war would impact his business, competition from India, the drugs he has in the pipeline and how close we are to a cure for cancer. He speaks exclusively on “Bloomberg Markets: Asia” from the sidelines of the Bloomberg Invest Asia event in Hong Kong.

Recent Videos

Featured Partners

image beaconimage beaconimage beacon